Pharmacological reversal of synaptic and network pathology in human MECP2‐KO neurons and cortical organoids
暂无分享,去创建一个
T. Sejnowski | A. Muotri | H. Ulrich | C. Trujillo | F. Zanella | P. Negraes | Leon Tejwani | Sarah Romero | Charles A. Thomas | C. Carromeu | Jason W. Adams | Allan Acab | Ben Tsuda | N. Sodhi | Katherine M Fichter
[1] P. Shannon,et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. , 2003, Genome research.
[2] Eric C. Griffith,et al. Characterization of human mosaic Rett syndrome brain tissue by single-nucleus RNA sequencing , 2018, Nature Neuroscience.
[3] H. Zoghbi,et al. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 , 1999, Nature Genetics.
[4] Madeline A. Lancaster,et al. Human cerebral organoids recapitulate gene expression programs of fetal neocortex development , 2015, Proceedings of the National Academy of Sciences.
[5] Thomas Miconi,et al. Biologically plausible learning in recurrent neural networks reproduces neural dynamics observed during cognitive tasks , 2016, bioRxiv.
[6] Stephen D. Shea,et al. MECP2 regulates cortical plasticity underlying a learned behaviour in adult female mice , 2016, Nature Communications.
[7] S. Moriguchi. Pharmacological study on Alzheimer's drugs targeting calcium/calmodulin-dependent protein kinase II. , 2011, Journal of pharmacological sciences.
[8] F. Hanefeld,et al. An update on clinically applicable diagnostic criteria in Rett syndrome. Comments to Rett Syndrome Clinical Criteria Consensus Panel Satellite to European Paediatric Neurology Society Meeting, Baden Baden, Germany, 11 September 2001. , 2002, European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society.
[9] S. Pati,et al. Rett Syndrome: Reaching for Clinical Trials , 2015, Neurotherapeutics.
[10] R. Kooy,et al. The GABAA Receptor as a Therapeutic Target for Neurodevelopmental Disorders , 2015, Neuron.
[11] M. Zaks,et al. Synaptic noise induces intermittent oscillatory-quiescent state transitions in a spiking network model , 2017, 1709.09748.
[12] Thomas J. Raub,et al. Discovery of N-[(3R)-1-azabicyclo[2.2.2]oct-3-yl]furo[2,3-c]pyridine-5-carboxamide, an agonist of the alpha7 nicotinic acetylcholine receptor, for the potential treatment of cognitive deficits in schizophrenia: synthesis and structure--activity relationship. , 2006, Journal of medicinal chemistry.
[13] Huanming Yang,et al. An atlas of the protein-coding genes in the human, pig, and mouse brain , 2020, Science.
[14] G. Mandel,et al. MeCP2 Is Critical for Maintaining Mature Neuronal Networks and Global Brain Anatomy during Late Stages of Postnatal Brain Development and in the Mature Adult Brain , 2012, The Journal of Neuroscience.
[15] A. Bird,et al. Rett Syndrome: Crossing the Threshold to Clinical Translation , 2016, Trends in Neurosciences.
[16] Peter J. Park,et al. Somatic mutation in single human neurons tracks developmental and transcriptional history , 2015, Science.
[17] David A. Orlando,et al. Global transcriptional and translational repression in human-embryonic-stem-cell-derived Rett syndrome neurons. , 2013, Cell stem cell.
[18] A. L. Camp,et al. Swimming muscles power suction feeding in largemouth bass , 2015, Proceedings of the National Academy of Sciences.
[19] D. Buonomano,et al. Complexity without chaos: Plasticity within random recurrent networks generates robust timing and motor control , 2012, 1210.2104.
[20] Yen-Chu Lin,et al. Defective GABAergic neurotransmission in the nucleus tractus solitarius in Mecp2-null mice, a model of Rett syndrome , 2018, Neurobiology of Disease.
[21] Max F. Oginsky,et al. Alterations in the cholinergic system of brain stem neurons in a mouse model of Rett syndrome. , 2014, American journal of physiology. Cell physiology.
[22] Terrence J. Sejnowski,et al. Simple framework for constructing functional spiking recurrent neural networks , 2019, Proceedings of the National Academy of Sciences.
[23] M. Pike,et al. Somatic Mutation , 1965, British medical journal.
[24] M. Higley,et al. Acetylcholine as a Neuromodulator: Cholinergic Signaling Shapes Nervous System Function and Behavior , 2012, Neuron.
[25] K. Delaney,et al. MeCP2 Mutation Results in Compartment-Specific Reductions in Dendritic Branching and Spine Density in Layer 5 Motor Cortical Neurons of YFP-H Mice , 2012, PloS one.
[26] A. Yaroshinsky,et al. A Double-Blind, Randomized, Placebo-Controlled Clinical Study of Trofinetide in the Treatment of Rett Syndrome. , 2017, Pediatric neurology.
[27] Eric C. Griffith,et al. Brain-Specific Phosphorylation of MeCP2 Regulates Activity-Dependent Bdnf Transcription, Dendritic Growth, and Spine Maturation , 2006, Neuron.
[28] J. Lupski,et al. Altered neuronal network and rescue in a human MECP2 duplication model , 2015, Molecular Psychiatry.
[29] S. Moshé,et al. Pharmacologic Treatment of Rett Syndrome With Glatiramer Acetate. , 2016, Pediatric neurology.
[30] Stephen T. C. Wong,et al. MeCP2, a Key Contributor to Neurological Disease, Activates and Represses Transcription , 2008, Science.
[31] Gene W. Yeo,et al. Complex Oscillatory Waves Emerging from Cortical Organoids Model Early Human Brain Network Development. , 2019, Cell stem cell.
[32] Christian Rosenmund,et al. MeCP2 Controls Excitatory Synaptic Strength by Regulating Glutamatergic Synapse Number , 2007, Neuron.
[33] A. Muotri,et al. Brain Organoids as Tools for Modeling Human Neurodevelopmental Disorders. , 2019, Physiology.
[34] Daniele Linaro,et al. Pyramidal Neurons Derived from Human Pluripotent Stem Cells Integrate Efficiently into Mouse Brain Circuits In Vivo , 2013, Neuron.
[35] Fred H. Gage,et al. A Model for Neural Development and Treatment of Rett Syndrome Using Human Induced Pluripotent Stem Cells , 2010, Cell.
[36] S. Duan,et al. Loss of MeCP2 in cholinergic neurons causes part of RTT-like phenotypes via α7 receptor in hippocampus , 2016, Cell Research.
[37] M. Johnston,et al. Neurobiology of Rett Syndrome , 2003, Journal of child neurology.
[38] Rodney C Samaco,et al. Epigenetic overlap in autism-spectrum neurodevelopmental disorders: MECP2 deficiency causes reduced expression of UBE3A and GABRB3. , 2005, Human molecular genetics.
[39] M. Sur,et al. Pharmacological enhancement of KCC2 gene expression exerts therapeutic effects on human Rett syndrome neurons and Mecp2 mutant mice , 2019, Science Translational Medicine.
[40] Ryan E. Mills,et al. Intersection of diverse neuronal genomes and neuropsychiatric disease: The Brain Somatic Mosaicism Network , 2017, Science.
[41] Jim Selfridge,et al. The role of MeCP2 in the brain. , 2009, Annual review of cell and developmental biology.
[42] H. Zoghbi,et al. Learning and Memory and Synaptic Plasticity Are Impaired in a Mouse Model of Rett Syndrome , 2006, The Journal of Neuroscience.
[43] S. Nelson,et al. Intact Long-Term Potentiation but Reduced Connectivity between Neocortical Layer 5 Pyramidal Neurons in a Mouse Model of Rett Syndrome , 2009, The Journal of Neuroscience.
[44] D. Benke,et al. Impact on GABA systems in monogenetic developmental CNS disorders: Clues to symptomatic treatment , 2017, Neuropharmacology.
[45] Heather M. O'Leary,et al. Placebo‐controlled crossover assessment of mecasermin for the treatment of Rett syndrome , 2018, Annals of clinical and translational neurology.
[46] Allan R. Jones,et al. Conserved cell types with divergent features in human versus mouse cortex , 2019, Nature.
[47] Eric C. Griffith,et al. Derepression of BDNF Transcription Involves Calcium-Dependent Phosphorylation of MeCP2 , 2003, Science.
[48] A. Malykh,et al. Piracetam and Piracetam-Like Drugs , 2010, Drugs.
[49] Bing Zhang,et al. WebGestalt: an integrated system for exploring gene sets in various biological contexts , 2005, Nucleic Acids Res..
[50] E. Kirkness,et al. Somatic coding mutations in human induced pluripotent stem cells , 2011, Nature.
[51] H. Hakusui,et al. Pharmacokinetics of nefiracetam and three metabolites in humans and stereoselective hydroxylation of its pyrrolidine ring. , 1993, Xenobiotica; the fate of foreign compounds in biological systems.
[52] Joseph R Ecker,et al. Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain. , 2016, Cell reports.
[53] Meghan T. Miller,et al. Towards a better diagnosis and treatment of Rett syndrome: a model synaptic disorder , 2019, Brain : a journal of neurology.
[54] H. Sompolinsky,et al. Chaos in Neuronal Networks with Balanced Excitatory and Inhibitory Activity , 1996, Science.
[55] Heather M. O'Leary,et al. Safety, pharmacokinetics, and preliminary assessment of efficacy of mecasermin (recombinant human IGF-1) for the treatment of Rett syndrome , 2014, Proceedings of the National Academy of Sciences.
[56] Michael L. Gonzales,et al. The Role of MeCP2 in Brain Development and Neurodevelopmental Disorders , 2010, Current psychiatry reports.
[57] A. Muotri,et al. Modeling of TREX1-Dependent Autoimmune Disease using Human Stem Cells Highlights L1 Accumulation as a Source of Neuroinflammation. , 2017, Cell stem cell.
[58] Wei Wu,et al. Selective preservation of cholinergic MeCP2 rescues specific Rett-syndrome-like phenotypes in MeCP2stop mice , 2017, Behavioural Brain Research.
[59] C. Tronel,et al. Alpha-7 nicotinic acetylcholine receptor agonist treatment in a rat model of Huntington's disease and involvement of heme oxygenase-1 , 2018, Neural regeneration research.
[60] Ryan Gordon,et al. Functional and Mechanistic Neurotoxicity Profiling Using Human iPSC-Derived Neural 3D Cultures , 2018, Toxicological sciences : an official journal of the Society of Toxicology.
[61] N. Craddock,et al. MECP2 structural and 3′‐UTR variants in schizophrenia, autism and other psychiatric diseases: A possible association with autism , 2004, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.
[62] J. Clayton-Smith,et al. Angelman syndrome phenotype associated with mutations inMECP2, a gene encoding a methyl CpG binding protein , 2001, Journal of medical genetics.
[63] R. Robinson,et al. Double-blind treatment of apathy in patients with poststroke depression using nefiracetam. , 2009, The Journal of neuropsychiatry and clinical neurosciences.
[64] Anders M. Dale,et al. A human neurodevelopmental model for Williams syndrome , 2016, Nature.
[65] Rodney C. Samaco,et al. GABAergic dysfunction mediates autism-like stereotypies and Rett syndrome phenotypes , 2010, Nature.